Analysed HLS THERAPEUTICS INC (HLTRF:OTCMKTS) News Sources
Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
18-11-2025
yahoo.com
HLS Therapeutics Inc (HLTRF) (Q2 2026) Earnings Call Highlights: Cardiovascular Portfolio ...
12-08-2026
yahoo.com
What is the current price of HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The current price of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is $2.82.
HLS THERAPEUTICS INC (HLTRF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) since the previous trading day is $0.102.
HLS THERAPEUTICS INC (HLTRF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of HLS THERAPEUTICS INC (HLTRF:OTCMKTS) since the previous trading day is 3.7528%.
What is the most recent average sentiment score for HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The most recent average sentiment score for HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for HLS THERAPEUTICS INC (HLTRF:OTCMKTS)?
The most recent sentiment for HLS THERAPEUTICS INC (HLTRF:OTCMKTS) is .
SEC-8K** Filing Available For HLS THERAPEUTICS INC (HLTRF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.